d/chad63-cat
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 15, 2018 (NCT03341754)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03341754 | Phase 1 | Sep 15, 2018 | United States Agency for International Development, United States Army, United States Navy, University of Oxford |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| United States Agency for International Development | Government | 1 | 0 | 1 | 2018 |
| United States Army | Government | 1 | 1 | 1 | 2018 |
| United States Navy | Government | 1 | 0 | 1 | 2018 |
| University of Oxford | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1